Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05791474 |
Title | ATI-2231 With in Advanced Solid Tumor Malignancies Followed by ATI-2231 in Combination With Capecitabine in Patients With Hormone Receptor-positive and HER2 Negative Metastatic Breast Cancer |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Washington University School of Medicine |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries |